Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Asset Utilization Ratio (2021 - 2023)

Gain Therapeutics has reported Asset Utilization Ratio over the past 3 years, most recently at 0.0 for Q4 2023.

  • Quarterly results put Asset Utilization Ratio at 0.0 for Q4 2023, down 36.87% from a year ago — trailing twelve months through Dec 2023 was 0.0 (down 36.87% YoY), and the annual figure for FY2023 was 0.0, down 41.83%.
  • Asset Utilization Ratio for Q4 2023 was 0.0 at Gain Therapeutics, down from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for GANX hit a ceiling of 0.01 in Q1 2023 and a floor of 0.0 in Q1 2021.
  • Median Asset Utilization Ratio over the past 3 years was 0.0 (2021), compared with a mean of 0.0.
  • Biggest five-year swings in Asset Utilization Ratio: surged 421.34% in 2022 and later plummeted 52.47% in 2023.
  • Gain Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 44.74% to 0.01 in 2022, then crashed by 36.87% to 0.0 in 2023.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q4 2023), 0.0 (Q3 2023), and 0.0 (Q2 2023) per Business Quant data.